» Articles » PMID: 22737580

Fanconi Anemia Proteins and Their Interacting Partners: a Molecular Puzzle

Overview
Journal Anemia
Publisher Wiley
Date 2012 Jun 28
PMID 22737580
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, Fanconi anemia (FA) has been the subject of intense investigations, primarily in the DNA repair research field. Many discoveries have led to the notion of a canonical pathway, termed the FA pathway, where all FA proteins function sequentially in different protein complexes to repair DNA cross-link damages. Although a detailed architecture of this DNA cross-link repair pathway is emerging, the question of how a defective DNA cross-link repair process translates into the disease phenotype is unresolved. Other areas of research including oxidative metabolism, cell cycle progression, apoptosis, and transcriptional regulation have been studied in the context of FA, and some of these areas were investigated before the fervent enthusiasm in the DNA repair field. These other molecular mechanisms may also play an important role in the pathogenesis of this disease. In addition, several FA-interacting proteins have been identified with roles in these "other" nonrepair molecular functions. Thus, the goal of this paper is to revisit old ideas and to discuss protein-protein interactions related to other FA-related molecular functions to try to give the reader a wider perspective of the FA molecular puzzle.

Citing Articles

Genetics, diet, microbiota, and metabolome: partners in crime for colon carcinogenesis.

La Vecchia M, Sala G, Sculco M, Aspesi A, Dianzani I Clin Exp Med. 2024; 24(1):248.

PMID: 39470880 PMC: 11522171. DOI: 10.1007/s10238-024-01505-x.


Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia.

Chihanga T, Vicente-Munoz S, Ruiz-Torres S, Pal B, Sertorio M, Andreassen P Cancers (Basel). 2022; 14(8).

PMID: 35454946 PMC: 9025423. DOI: 10.3390/cancers14082040.


Fanconi anemia A protein participates in nucleolar homeostasis maintenance and ribosome biogenesis.

Gueiderikh A, Maczkowiak-Chartois F, Rouvet G, Souquere-Besse S, Apcher S, Diaz J Sci Adv. 2021; 7(1).

PMID: 33523834 PMC: 7775781. DOI: 10.1126/sciadv.abb5414.


AMP-activated protein kinase is involved in the activation of the Fanconi anemia/BRCA pathway in response to DNA interstrand crosslinks.

Chun M, Kim S, Hwang S, Kim B, Kim H, Choi H Oncotarget. 2016; 7(33):53642-53653.

PMID: 27449087 PMC: 5288211. DOI: 10.18632/oncotarget.10686.


The Fanconi Anemia C Protein Binds to and Regulates Stathmin-1 Phosphorylation.

Magron A, Elowe S, Carreau M PLoS One. 2015; 10(10):e0140612.

PMID: 26466335 PMC: 4605623. DOI: 10.1371/journal.pone.0140612.


References
1.
Futaki M, Igarashi T, Watanabe S, Kajigaya S, Tatsuguchi A, Wang J . The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis. 2002; 23(1):67-72. DOI: 10.1093/carcin/23.1.67. View

2.
Yamashita T, Barber D, Zhu Y, Wu N, DAndrea A . The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci U S A. 1994; 91(14):6712-6. PMC: 44273. DOI: 10.1073/pnas.91.14.6712. View

3.
Zhi G, Wilson J, Chen X, Krause D, Xiao Y, Jones N . Fanconi anemia complementation group FANCD2 protein serine 331 phosphorylation is important for fanconi anemia pathway function and BRCA2 interaction. Cancer Res. 2009; 69(22):8775-83. PMC: 5912675. DOI: 10.1158/0008-5472.CAN-09-2312. View

4.
Otsuki T, Young D, Sasaki D, Pando M, Li J, Manning A . Fanconi anemia protein complex is a novel target of the IKK signalsome. J Cell Biochem. 2002; 86(4):613-23. DOI: 10.1002/jcb.10270. View

5.
Froom P, AGHAI E, Dobinsky J, Quitt M, Lahat N . Reduced natural killer activity in patients with Fanconi's anemia and in family members. Leuk Res. 1987; 11(2):197-9. DOI: 10.1016/0145-2126(87)90026-9. View